When a company such as Surmodics splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the SRDX split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Surmodics shares, starting with a $10,000 purchase of SRDX, presented on a split-history-adjusted basis factoring in the complete SRDX split history.

About Surmodics

Surmodics provides performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. Co.'s segments are: Medical Device, which develops and manufactures its own proprietary vascular intervention medical device products as well as is engaged in proprietary surface modification coating technologies that impart lubricity, pro-healing, biocompatibility characteristics, and drug-delivery capabilities; and IVD, which develops, manufactures and sells chemical and biological components for IVD immunoassay tests and molecular diagnostic tests for the diagnostic and biomedical research markets. According to our SRDX split history records, Surmodics has had 1 split.

SRDX Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved